Senseonics’ Eversense is an FDA-approved long-term implantable sensor with markets in diabetes and wellness, implying long-term growth for SENS stock./n
Read MoreThe Senseonics Price Will Start to Reflect the Key Advantage of Its Product
2021-07-13T18:37:12-04:00July 13th, 2021|